Methods of treating disease with dichlorphenamide
AssigneeStrongbridge Dublin Limited
InventorFredric Jay COHEN
Life of this patent
Estimating the term…
Abstract
Provided herein are methods for administering dichlorphenamide, or a pharmaceutically acceptable salt thereof, to a subject in need thereof, wherein the subject is also being administered an organic anion transporter-1 (OAT1) substrate to treat an associated disease or disorder. The method comprises administering to the subject a therapeutically effective amount of dichlorphenamide, or a pharmaceutically acceptable salt thereof, and monitoring the subject for signs and symptoms of toxicity and clinical response associated with the OAT1 substrate.
Claims2
1-12. (canceled)
A method of administering dichlorphenamide to treat primary hyperkalemic periodic paralysis or primary hypokalemic periodic paralysis in a human patient in need thereof, wherein the patient is also being administered oseltamivir for the treatment of a disease or disorder, the method comprising:
- discontinuing administration of the oseltamivir to said patient, and
- administering dichlorphenamide in a tablet form to said patient at an initial dose of 50 mg once or twice daily, thereby avoiding concomitant administration of oseltamivir and dichlorphenamide to said patient.
Dependencies are inferred from the claim text.